Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 11 analysts

Fate Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -6.6%, and profit growth estimate of 4.1% for FY26, based on top 11 analyst calls.